A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery.
Korzeniowski MA, Crook JM, Bowes D, Gaztañaga M, Ots A, Jazwal J, Rose J, Tétreault-Laflamme A, Pilote L, Halperin R, Kim D, Petrik D, Araujo C, Bachand F.
Korzeniowski MA, et al. Among authors: tetreault laflamme a.
Brachytherapy. 2018 May-Jun;17(3):530-536. doi: 10.1016/j.brachy.2017.12.005. Epub 2018 Feb 2.
Brachytherapy. 2018.
PMID: 29398594
Clinical Trial.